Cystic fibrosis: potential management through manipulation of the secretory process in affected exocrine glands
Mangos, J.A.
Progress in Clinical and Biological Research 34: 111-117
1979
ISSN/ISBN: 0361-7742 PMID: 531049 Document Number: 146007
Document emailed within 1 workday
Related Documents
Sato, K. 1984: Differing luminal potential difference of cystic fibrosis and control sweat secretory coils in vitro American Journal of Physiology 247(4 Pt 2): R646-R649Fedirko, N.V.; Klevets', M.I. 2000: Influence of eosin y and orthovanadate on the steady-state of Ca(+)2 entry into secretory cells of exocrine glands and their spontaneous secretion Fiziolohichnyi Zhurnal 46(5): 3-8
Czerny, K.; Romanowska, J.; Kifer-Wysocka, E.; Matysiak, W.ło.; Masłyk, T. 2004: High doses of atorvastatin (Sortis) modify the secretory process in the exocrine portion of the pancreas Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 59(2): 52-56
Boué, J.; Muller, F.; Simon-Bouy, B.; Faure, C.; Boué, A. 1991: Consequences of prenatal diagnosis of cystic fibrosis on the reproductive attitudes of parents of affected children Prenatal Diagnosis 11(4): 209-214
Hein, J.; Brock, J.; David, A.; Grimm, J. 1978: Immunoglobulins (IgG, secretory-IgA) and function of parotid gland in children with cystic fibrosis, with bronchial asthma, and with chronic bronchitis Zeitschrift für Erkrankungen der Atmungsorgane 151(3): 222-230
Redl, B.; Wojnar, P.; Ellemunter, H.; Feichtinger, H. 1998: Identification of a lipocalin in mucosal glands of the human tracheobronchial tree and its enhanced secretion in cystic fibrosis Laboratory Investigation; A Journal of Technical Methods and Pathology 78(9): 1121-1129
Tirouvanziam, R.; Desternes, M.; Saari, A.; Puchelle, E.; Péault, B.; Chinet, T. 1998: Bioelectric properties of human cystic fibrosis and non-cystic fibrosis fetal tracheal xenografts in SCID mice American Journal of Physiology 274(4): C875-C882
Denter, M.; Ramsay, M.; Jenkins, T. 1992: Cystic fibrosis. Part I. Frequency of the delta F508 mutation in South African families with cystic fibrosis South African Medical Journal 82(1): 7-10
Kirkpatrick, C.A.; Lecocq, R.; Lamy, F.; Baran, D.; Rodesch, F.; Dumont, J.E. 1987: A pitfall in analysis of proteins synthesized by sweat glands from patients with cystic fibrosis by two-dimensional gel electrophoresis and double-label autoradiography Clinical Chemistry 33(12): 2310
Khan, M.A.; Litt, M.; Kwart, H.; Rosenlund, M.L. 1973: Measurement of colloid zeta potential as a test for cystic fibrosis secretion factor Texas Reports on Biology and Medicine 31(4): 665-683
Panitch, H.B.; Schidlow, D.V. 1987: Management of hemoptysis in cystic fibrosis Delaware Medical Journal 59(2): 95-98
Lees, C.M.; Smyth, R.L. 2000: The current management of cystic fibrosis International Journal of Clinical Practice 54(3): 171-179
Wallace, C.S.; Hall, M.; Kuhn, R.J. 1993: Pharmacologic management of cystic fibrosis Clinical Pharmacy 12(9): 657-674; Quiz: 700-701
Norman, A.P. 1975: Medical management of cystic fibrosis PhysioTherapy 61(8): 242-244
Byrne, S.; David, T.J. 1993: Management of the child with cystic fibrosis British Journal of Hospital Medicine 50(8): 445-451
Labbé, A.; Bellon, G.; Héraud, M.C.; Arbre, P.; Goddon, G.; Alton, E. 1991: Determination of nasal transepithelial potential difference (DDPTE) in cystic fibrosis. Analysis of a simplified measurement technique Archives Francaises de Pediatrie 48(9): 617-620
Jiménez Carlo, R. 1997: Biliary complications and management of cystic fibrosis Boletin de la Asociacion Medica de Puerto Rico 89(4-6): 70-76
Kehrer, B.; Koch, A.; Bettex, M. 1982: Surgical management of pneumothorax in cystic fibrosis Schweizerische Rundschau für Medizin Praxis 71(14): 589-602
Ajello, A.; Miggiano, G.A.D. 2004: Dietetic management of cystic fibrosis: intervention strategies La Clinica Terapeutica 155(11-12): 557-564
Yuksel, H.; Yilmaz, O. 2011: A new model for cystic fibrosis management: control concept Pneumologia 60(3): 150-154